Abstract
4114Background: Gemcitabine + nab-paclitaxel (G/nab-P) is a standard first-line option for advanced PAC. Evofosfamide (Evo, previously known as TH-302) is a hypoxia-activated prodrug of bromo-isoph...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
